Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer

Published:2018-04 Issue:2 Volume:173 Page:515-528.e17
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Lee Suk Hyung,Hu Wenhuo,Matulay Justin T.,Silva Mark V.,Owczarek Tomasz B.,Kim Kwanghee,Chua Chee Wai,Barlow LaMont J.,Kandoth Cyriac,Williams Alanna B.,Bergren Sarah K.,Pietzak Eugene J.,Anderson Christopher B.,Benson Mitchell C.,Coleman Jonathan A.,Taylor Barry S.,Abate-Shen Cory,McKiernan James M.,Al-Ahmadie Hikmat,Solit David B.,Shen Michael M.

Funder

NIH

Urology Care Foundation Research Scholar Award

Urology Care Foundation Residency Research Award

Cycle for Survival

Bladder Cancer Advocacy Network

TJ Martell Foundation

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference61 articles.

1. Molecular mechanisms of squamous differentiation in urothelial cell carcinoma: a paradigm for molecular subtyping of urothelial cell carcinoma of the bladder;Adam;Urol. Oncol.,2015

2. Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma;Al-Ahmadie;J. Pathol.,2011

3. Deciphering signatures of mutational processes operative in human cancer;Alexandrov;Cell Rep.,2013

4. Organoid models of human and mouse ductal pancreatic cancer;Boj;Cell,2015

5. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening;Broutier;Nat. Med.,2017

Cited by 592 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FL118: A potential bladder cancer therapeutic compound targeting H2A.X identified through library screening;Bioorganic Chemistry;2024-12

2. Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine;Life;2024-09-10

3. Primary liver cancer organoids and their application to research and therapy;Journal of the National Cancer Center;2024-09

4. Carboxylated mesoporous silica nanoparticle-nucleic acid chimera conjugate-assisted delivery of siRNA and doxorubicin effectively treat drug-resistant bladder cancer.;Biomedicine & Pharmacotherapy;2024-09

5. Precision oncology: current and future platforms for treatment selection;Trends in Cancer;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3